SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
16-Mar-22 5:09 PM View: | Esperion Therapeutics, Inc. (ESPR) | 14-Mar-22 | Grant | 37,000 | -- | -- | 81% 45.75K to 82.75K | |
01-Nov-21 4:48 PM View: | Esperion Therapeutics, Inc. (ESPR) | 29-Oct-21 | Grant | 18,700 | -- | -- | 74% 25.15K to 43.85K | |
29-Jan-21 5:01 PM View: | Esperion Therapeutics, Inc. (ESPR) | 28-Jan-21 | Grant | 5,000 | -- | -- | 27% 18.62K to 23.62K | |
03-Jan-20 4:27 PM View: | Esperion Therapeutics, Inc. (ESPR) | 02-Jan-20 | Grant | 7,525 | -- | -- | 68% 11.15K to 18.67K | |
05-Apr-19 5:23 PM View: | Esperion Therapeutics, Inc. (ESPR) | 03-Apr-19 | Market Sale (Planned) | 8,000 | $42.88 | $343,045.00 | 259% 3.09K to 11.09K | (34%) |
03-Jan-18 6:01 PM View: | Esperion Therapeutics, Inc. (ESPR) | 02-Jan-18 | Option Exercise | 17,892 | $3.70 | $66,200.40 | 1491% 1.2K to 19.09K |